---
figid: PMC6167501__bsr-38-bsr20180511-g3
figlink: /pmc/articles/PMC6167501/figure/F3/
number: F3
caption: Malignant transformation in melanocytes can require combinations of frequently
  seen genetic defects, which lead to melanoma development. These mutants often elicit
  Akt over-activation, leading to constitutive pathway activation (indicated by thicker
  arrows). Constitutive activation of PI3K-Akt signaling impairs cell cycle regulation,
  favoring tumor initiation and progression. Mutations can be mutually exclusive or
  coexist. For example, mutated NRAS (NRASmut) and BRAF (BRAFV600E), from Ras-Raf-MEK-ERK
  pathway, rarely occur in the same melanoma cell, whereas BRAFV600E and PTEN function
  loss (PTENdel) appears in 20% of melanomas. NRASmut, a well-described mutation in
  melanoma cells, may also lead to hyperactivation of the PI3K-Akt pathway. PI3K mutation
  itself (p110mut) is a rare condition. mTORC1mut increases protein translation and
  cell proliferation, favoring melanoma development. Also, mTORC2mut enhances Akt
  activation, collaborating with the maintenance of constitutive activation of PI3K-Akt
  pathway in cancer.
pmcid: PMC6167501
papertitle: 'Exploring major signaling cascades in melanomagenesis: a rationale route
  for targetted skin cancer therapy.'
reftext: PaolaÂ M. Dantonio, et al. Biosci Rep. 2018 Oct 31;38(5):BSR20180511.
pmc_ranked_result_index: '526'
pathway_score: 0.9670855
filename: bsr-38-bsr20180511-g3.jpg
figtitle: PI3K-Akt pathway activity in melanoma
year: '2018'
organisms: Homo sapiens
ndex: 60420565-dece-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6167501__bsr-38-bsr20180511-g3.html
  '@type': Dataset
  description: Malignant transformation in melanocytes can require combinations of
    frequently seen genetic defects, which lead to melanoma development. These mutants
    often elicit Akt over-activation, leading to constitutive pathway activation (indicated
    by thicker arrows). Constitutive activation of PI3K-Akt signaling impairs cell
    cycle regulation, favoring tumor initiation and progression. Mutations can be
    mutually exclusive or coexist. For example, mutated NRAS (NRASmut) and BRAF (BRAFV600E),
    from Ras-Raf-MEK-ERK pathway, rarely occur in the same melanoma cell, whereas
    BRAFV600E and PTEN function loss (PTENdel) appears in 20% of melanomas. NRASmut,
    a well-described mutation in melanoma cells, may also lead to hyperactivation
    of the PI3K-Akt pathway. PI3K mutation itself (p110mut) is a rare condition. mTORC1mut
    increases protein translation and cell proliferation, favoring melanoma development.
    Also, mTORC2mut enhances Akt activation, collaborating with the maintenance of
    constitutive activation of PI3K-Akt pathway in cancer.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - MAP2K2
  - MAP2K1
  - SART3
  - MAPK3
  - PIK3CB
  - MUT
  - AKT2
  - PIK3CA
  - PTEN
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PDPK1
  - PIK3R6
  - AKT3
  - AKT1
  - PIK3R4
  - PIK3R5
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: mut
  symbol: MUT
  source: hgnc_symbol
  hgnc_symbol: MUT
  entrez: '4594'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PDPK1
  symbol: PDPK1
  source: hgnc_symbol
  hgnc_symbol: PDPK1
  entrez: '5170'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
chemicals: []
diseases: []
figid_alias: PMC6167501__F3
redirect_from: /figures/PMC6167501__F3
figtype: Figure
---
